
Varenicline tartrate is a premium-grade, high-purity selective α4β2 nicotinic acetylcholine receptor partial agonist carrying CAS number 375815-87-5. Refined under strict pharmaceutical quality compliance, this active pharmaceutical ingredient (API) exhibits exceptional efficacy in the development of specialized smoking cessation therapeutic treatments. Therefore, it provides reliable stability in sensitive medicinal formulations and ensures consistent therapeutic activity. Consequently, it serves as an ideal core choice for specialized pharmaceutical manufacturing lines, clinical research, and modern medical synthesis processes globally.
Excellent thermal stability and outstanding biological affinity provide a distinct operational edge. This advantage is crucial when engineering modern high-performance smoking cessation formulations. This active pharmaceutical solid operates by facilitating the systemic regulation of targeted nicotinic pathways. Thus, it successfully enhances the therapeutic profiling of targeted medicinal matrices. It supplies the exact chemical mechanisms required to induce rapid synthetic steps. As a consequence, it does this without altering raw mass density uniformity.
It assists formulation experts in maintaining strict active concentration uniformity. This balance is critical across high-speed pharmaceutical synthesis operations and continuous filling lines. Hence, it mitigates trace impurity risks within automated volumetric dosing machinery. For instance, specialized production facilities incorporate this refined substance. It acts as a core active component in targeted neurological management and specialized treatment cycles. Consequently, it maximizes the technical throughput of automated formulation machinery. Consequently, Zyntex coordinates clean-room synthesis paths to eliminate downstream moisture-induced alterations from your factory schedule.
In addition to this, Zyntex coordinates climate-controlled logistics for manufacturing operations. This service supports advanced pharmaceutical synthesis centers globally. The compound maintains its refined molecular geometry under strict storage parameters. Therefore, it prevents temperature-induced degradation during automated mechanical blending steps. It advances contemporary medicinal engineering by providing a thoroughly analyzed, highly predictable raw material.
This high-purity active compound delivers crucial technical value within these four primary industrial sectors:
Primary ingredient for advanced smoking cessation and anti-addiction formulations.
Essential reagent for studying nicotinic receptor partial agonist kinetics.
Active component in specialized neurological growth control mediums.
Reference material for validating pharmaceutical ingredient potency.
| Parameter | Standard Value |
|---|---|
| Product Name | Varenicline tartrate |
| Assay / Purity | Min 99.0% |
| Appearance | White to off-white powder |
| CAS Number | 375815-87-5 |
⚠️ SAFETY & HANDLING (Moderate Hazard): Varenicline tartrate is a potent pharmaceutical agent. Handling: Use appropriate PPE (gloves, safety goggles, respiratory protection) and ensure adequate ventilation to prevent dust exposure. Storage: Store in a cool, dry, and dark area. Keep containers tightly closed. Review the full Safety Data Sheet (SDS) for detailed facility protocols.